1 / 5

Insights from the Oncologic Drugs Advisory Committee Public Hearing - March 4, 2005

The Oncologic Drugs Advisory Committee convened on March 4, 2005, to discuss critical issues surrounding cancer treatment and drug approval. Notable contributors included Peter Lurie from the Public Citizens Health Research Group, Laurie Fenton representing the Lung Alliance Organization, Selma Schimmel, and Rosalind Brannigan from Vital Options International. This hearing emphasized the importance of public input in drug evaluation processes and highlighted the concerns of various stakeholder groups regarding oncologic therapies.

aolani
Télécharger la présentation

Insights from the Oncologic Drugs Advisory Committee Public Hearing - March 4, 2005

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Oncologic Drugs Advisory Committee Open Public Hearing March 4, 2005

  2. 1. Peter Lurie Public Citizens Health Research Group

  3. Laurie Fenton • Lung Alliance Organization

  4. Selma Schimmel • Vital Options International

  5. 4. Rosalind Brannigan

More Related